Coronary Artery Disease and Renal Failure Registry

• Conditions: Coronary Artery Disease; Renal Failure

• Registration Number: NCT00679419
• Lead Sponsor: Institut für Klinisch-Kardiovaskuläre Forschung GmbH

Brief Summary

It is the aim of the multi-centric and prospective registry to analyze in patients with CAD the impact of different grades of renal failure on the outcome and course of the patients and to correlate these with clinical variables.

In particular, the registry has the following objectives:

* prospective consecutive assessment of all patients with coronary artery disease and renal failure in the participating hospitals of the registry

* evaluation of the outcome and course of patients with regard to their different stages of renal failure at baseline

* analysis of the impact of different therapeutic strategies on acute and long-term outcomes

* identification of clinical risk factors, novel biomarkers and genetic markers for an unfavorable long-term outcome

Detailed Description

Not available

Study Timeline

• Study Start: 2007-12
• Study First Submitted: 2008-05-14
• Study First Submitted QC: 2008-05-14
• Study First Posted: 2008-05-16
• Primary Completion: 2011-05
• Status Verified: 2012-10
• Last Update Submitted: 2012-11-01
• Last Update Posted: 2012-11-02
• Study Completion: 2013-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 3352

Inclusion Criteria

• Women and men >= 18 years of age
• Patients with actually performed interventional coronary angiography and there a documented coronary heart disease, defined as at least one documented stenosis >= 50 % in at least one main coronary vessel (Main steam; RCX; RIVA; RCA)
• European/Caucasian descent (European/Caucasian parents and grandparents)
• Availability of an urine, serum- and EDTA blood sample of the patient
• Documented consent of patients for handling of personal medical data, including a genetic analysis

Exclusion Criteria

• Patients who have been already recruited into this registry
• Patients with organ transplantations, apart from kidney transplantations
• Immunosuppressive therapy, apart from immunosuppressive therapy after kidney transplantation
• Patients with polycystic renal disease
• Pregnant and breastfeeding patients
• Known malignant tumor

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
all cause mortality	two years

Secondary Outcome Measures

Name	Time	Method
manner of death	two years	cardiac death; non-cardiac death; death of unknown cause

Trial Locations

Locations (32)

Universitätsklinikum Aachen; 🇩🇪 Aachen, Germany

Zentralklinik Bad Berka; 🇩🇪 Bad Berka, Germany

Herz- und Gefäßklinik Bad Neustadt; 🇩🇪 Bad Neustadt, Germany

Schüchtermann-Klinik; 🇩🇪 Bad Rothenfelde, Germany

Herzzentrum Brandenburg; 🇩🇪 Brandenburg, Germany

St.-Vincenz-Hospital; 🇩🇪 Coesfeld, Germany

Klinikum Lippe-Detmold; 🇩🇪 Detmold, Germany

Herzzentrum Duisburg; 🇩🇪 Duisburg, Germany

Evangelisches Krankenhaus Düsseldorf; 🇩🇪 Düsseldorf, Germany

Alfried Krupp Krankenhaus Essen; 🇩🇪 Essen, Germany

Scroll for more (22 remaining)